First Manhattan’s Natus Medical Inc NTUS Stock Holding History

First Manhattan’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$3K	–	1517
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	1309
2017 Q1	$3K	Hold	100	–	–	﹤0.01%	1323
2016 Q4	$3K	Hold	100	–	–	﹤0.01%	1304
2016 Q3	$3K	Hold	100	–	–	﹤0.01%	1321
2016 Q2	$3K	Hold	100	–	–	﹤0.01%	1385
2016 Q1	$3K	Hold	100	–	–	﹤0.01%	1303
2015 Q4	$4K	Hold	100	–	–	﹤0.01%	1289
2015 Q3	$3K	Hold	100	–	–	﹤0.01%	1325
2015 Q2	$4K	Hold	100	–	–	﹤0.01%	1329
2015 Q1	$3K	Hold	100	–	–	﹤0.01%	1370
2014 Q4	$3K	Hold	100	–	–	﹤0.01%	1389
2014 Q3	$2K	Hold	100	–	–	﹤0.01%	1389
2014 Q2	$2K	Hold	100	–	–	﹤0.01%	1361
2014 Q1	$2K	Hold	100	–	–	﹤0.01%	1342
2013 Q4	$2K	Hold	100	–	–	﹤0.01%	1310
2013 Q3	$1K	Buy	+100	New	+$1.34K	﹤0.01%	1346

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

First Manhattan's NTUS Position: Q3 2017 in Review

First Manhattan sold out of Natus Medical Inc (NTUS) in Q3 2017, closing a stake of 100 shares — an estimated $3K sold.

First Manhattan first reported a position in NTUS in Q3 2013 and held it in 16 quarters. The position peaked at $4K in Q4 2015. 198 funds tracked by Wall St. Rank hold NTUS as of Q3 2017.

First Manhattan reported no remaining Natus Medical Inc position as of Q3 2017 after selling out during the quarter.
First Manhattan sold 100 Natus Medical Inc shares in Q3 2017, an estimated $3K.
First Manhattan first reported a position in Natus Medical Inc in Q3 2013 and held it in 16 quarters.
First Manhattan's Natus Medical Inc position peaked at $4K in Q4 2015.
198 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2017.

Based on First Manhattan's 13F filing for Q3 2017, filed 25 Oct 2017.